General Archive
-
ArticlesLifeArc – advancing innovation in rare disease
We act as a trusted partner to transform the way rare diseases are identified and treated.
-
News releasesLifeArc elects new Board Chair to drive charity’s ambitious strategy
Dr Ian Gilham appointed new Chair of Trustees to succeed Dr John Stageman when he steps down on 4 April…
-
News releasesNew study explores unique approach to treat a rare liver disease
A research study looking into a new approach to treat primary sclerosing cholangitis (PSC) is progressing to clinical trials.
-
ArticlesCelebrating our inspirational women scientists
Today is the UN’s International Day of Women and Girls in Science and we are delighted to have so many inspiring…
-
ArticlesReflecting on 2021 – a year of progress
As we bid farewell to another challenging year, we reflect on our work with partners and colleagues in 2021.
-
News releasesLifeArc participates in Series A funding round for company developing pioneering new gene therapies for neurodegenerative diseases
Helping to progress an innovative gene therapy platform from the bench to a stage where it is progressing closer to…
-
News releasesLifeArc unveils new strategy and £1.3 billion spend to drive life-changing science
Aims to transform the way diseases such as motor neurone disease are prevented, identified and treated.
-
News releasesNew approach provides potential vaccine and treatment for Alzheimer’s
An antibody-based treatment and protein-based vaccine reduced Alzheimer’s symptoms in mouse models of the disease.
-
News releasesLifeArc invests in company developing personalised drug and digital combination treatments
LifeArc and partners announce a £13 million financing deal in Closed Loop Medicine to enable the company to develop further…
-
News releasesAccelerating the search for new treatments for neurodegenerative diseases
LifeArc and scientists in Italy develop a screening test that could help speed up the discovery of potential medicines to…
-
News releasesInvestigational treatment may reduce need for a ventilator for hospitalised COVID-19 patients
An oral drug may reduce the need for oxygen therapy and speed recovery of hospitalised COVID-19 patients. Early findings from…
-
News releasesThree new Trustees bring more skills and experience to LifeArc
A very warm welcome to three new Trustees who have joined our Board.